Catherine Sherwin, PhD, MSc
Adjunct Associate Professor, Department of Experimental and Clinical Pharmacology (ECP)
Contact
Email
Fax
Administrative Assistant
Name:
Lindsey Koverman
Phone:
Titles
Adjunct Associate Professor, Department of Experimental and Clinical Pharmacology (ECP)
Vice-Chair for Research (Pediatrics), Department of Pediatrics, Wright State University (WSU), Boonshoft School of Medicine (BSoM), Dayton Children's Hospital (DCH), Dayton, OH, USA
Education
PhD, The University of Otago, Dunedin School of Medicine, Dunedin, Otago, New Zealand
Focus: Medicine/Paediatrics, Paediatric Clinical Pharmacology
Master of Science in Clinical Investigation (MSCI), University of Utah, Salt Lake City (SLC), UT, USA
Emphasize: Patient-Centered Outcomes Research/Comparative Effectiveness Research
Master of Science in Pharmacy, Major: Pharmaceutical Sciences
Concentration: Clinical Toxicology
The College of Pharmacy, University of Florida
Gainesville, Florida, USA
Bachelor's degree with Honours in Animal Science, Lincoln University Canterbury, New Zealand Major: Toxicology and Immunology
Fellowships
Postdoctoral Fellowship in Pediatric Clinical Pharmacology, Cincinnati Children's Hospital Medical Center; Postdoctoral Fellowship in Paediatric Clinical Pharmacology, Dunedin School of Medicine, The University of Otago
Licensures and Certifications
Association of Clinical Research Professionals (ACRP) Certified Principal Investigator (CPI) Certification Status: Certified / Type: CPI / Expires: 11/30/2022
American Board of Clinical Pharmacology (ABCP) Diplomate of the American Board of Clinical Pharmacology (DABCP)
Biography
Dr. Catherine Sherwin is a Professor and Vice‐chair for research at the Department of Pediatrics, Wright State University Boonshoft School of Medicine, and Dayton Children's Hospital. She earned her Ph.D. at the University of Otago, Dunedin School of Medicine, New Zealand, in Paediatric Clinical Pharmacology in 2007. She then completed one year of postdoctoral training in Dunedin's Women’s and Children’s Health and then a two‐year T32 Fellowship training program in the Divisions of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center. She received board certification from the American Board of Clinical Pharmacology in 2011. Dr. Sherwin has expertise and experience in developing quantitative pharmacometric (PK/PD/PG) models in special populations, including pediatric and neonatal patients.
Expertise
Clinical Pediatric and Maternal-Fetal Pharmacology and Toxicology, Pediatric Clinical Research & Development, Clinical Trials, Clinical Trial Simulation, Personalized/Precision (Individualized) Medicine, Modeling and Simulation (Pharmacometrics), Optimal Trial Design, Therapeutics, Pharmacodynamics, Pharmacogenomics, Pharmacokinetics, Translational Research, Medical, and Environmental Toxicology
Research Summary/Interests
- Clinical Pharmacology
- Clinical Toxicology
- Clinical Research and Clinical Trials
Research Methods/Techniques
Clinical Pharmacology; Clinical Trials; Pharmacokinetics; Pharmacodynamics; Toxicology; Translational Research; in vivo; Clinical Study Design
Academic Interests and Focus
Clinical Pediatric and Maternal-Fetal Pharmacology and Toxicology; Pediatric Clinical Research & Development; Clinical Trials